Fregoso PJ

Language: Spanish
References: 10
Page: 58-63
PDF size: 61.69 Kb.

ABSTRACT

We review the mechanisms by which arterial hypertension induces target organs damage, particulary the heart, kidney, and vascular endothelium, which is manifested as ventricular hypertrophy, proteinuria, and renal failure and endothelial dysfunction. Furthermore, the effect of antihypertensive treatment in these situations is analyzed. Experimental and clinical studies show that angiotensin converting enzyme inhibitors (ACE inhibitors) and angiotensin II receptor antagonist drugs are more efficient than other antihypertensive treatments in the reversal of left ventricular hypertrophy and proteinuria, in delaying kidney damage and improving of endothelial function.

REFERENCES

1. Kaplan NM: Clinical Hypertension; 1998, 7a. ed. Williams & Wilkins, Baltimore, USA.

2. Hamet P: Apoptosis in target organs of Hypertension. Hypertension 1995; 26: 642-648.

3. Stefanec T: Endothelial apoptosis: could it have a role in the pathogenesis and treatment of disease? Chest 2000; 117(3): 841-54.

4. Ichihara S, Senbonmatsu T, Price E, Ichiki T, Gaffney A, Inagami T: Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation 2001; 104: 346-351.

5. Schmieder RE: Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies. JAMA 1996; 275(19): 1507-13.

6. Hamet P, deBlois D: Endothelial and myocyte apoptosis- role of angiotensin II. Can J Cardiol 2001; 17(suppl A): 26A-8A.

7. Hornych A, Asmar R: Microalbuminuria and arterial hypertension. Presse Med 1999; 28(11): 597-604.

8. Maki DD, Ma JZ, Louis TA, Kasiske BL: Long-term effects of antihypertensive agents on proteinuria and renal function. Arch Intern Med 1995; 155: 1073-80.

9. Schiffrin EL: Effects of antihypertensive drugs on vascular remodeling: do they predictor outcome in response to antihypertensive therapy? Curr Opin Nephrol Hypertens, 2001; 10(5): 617-24.

10. Horning B, Landmesser U, Kohler C, Ahlersmann D, Spiekermann S, Christoph A, Tatge H, Drexler H: Comparative effect of ACE inhibition and angiotensin II type I receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase. Circulation 2001; 103(6): 799-805.